Shirley-based Luitpold Pharmaceuticals Inc. has acquired PharmaForce, based in Columbus, Ohio, the company announced Wednesday.

Under the agreement, Luitpold purchased all of the stock of PharmaForce, a privately held drug manufacturer founded in 1999. Terms of the deal were not disclosed.

A Luitpold subsidiary, American Regent Inc., which manufactures generic injectable drugs and iron products, will market the PharmaForce product line.

Luitpold chief executive Mary Jane Helenek said the acquisition "provides an immediate expansion of our R&D pipeline, increased manufacturing capacity and establishes a base from which to move forward with different injectable dosage forms to take advantage of the fast-growing generic injectable market."

The transaction was completed Dec. 29.

advertisement | advertise on newsday

PharmaForce has three manufacturing and research and development facilities and about 100 employees.

Helenek said that PharmaForce's management team and employees would be staying on and that the company plans to build a fourth manufacturing facility in the Midwest.

Luitpold has about 500 employees, including 400 on Long Island. The company is a subsidiary of Tokyo-based Daiichi-Sankyo Co. Ltd.